Xencor to Present Initial Phase 1 Data for XmAb819 Bispecific Antibody in Renal Cell Carcinoma at AACR-NCI-EORTC Conference

Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, announced the...

October 15, 2025 | Wednesday | News
Daiichi Sankyo Showcases Transformative ADC Data at ESMO 2025

Back-to-back Presidential Symposium presentations of ENHERTU from DESTINY-Breast11 and DESTINY-Breast05 demonstrate its potential to become a foundat...

October 14, 2025 | Tuesday | News
AstraZeneca at ESMO 2025: Advancing Oncology Across Breast, Bladder, Gastric, Lung, and Prostate Cancers

Presidential Symposium will feature DESTINY-Breast11 and DESTINY-Breast05, underscoring potential of ENHERTU® (fam-trastuzumab deruxtecan-nxki) in ...

October 14, 2025 | Tuesday | News
ABLi Therapeutics Announces Positive Phase 2 Results for Risvodetinib in Untreated Parkinson’s Disease

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosin...

October 10, 2025 | Friday | News
Philips Unveils Next-Generation CT and Helium-Free MR Systems to Transform Precision and Sustainability in Radiation Therapy

New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term value Philips deb...

September 29, 2025 | Monday | News
Johnson & Johnson’s RYBREVANT® Plus LAZCLUZE® Demonstrates Superior Resistance Prevention Over Osimertinib in EGFR-Mutated Lung Cancer

Johnson & Johnson announced new analyses from the Phase 3 MARIPOSA study demonstrating that first-line treatment with RYBREVANT® (amivantamab-vmj...

September 08, 2025 | Monday | News
BIO 2025 Closes in Boston with Global Biotech Leaders Uniting for a New Era of Innovation and Impact

The BIO International Convention 2025 concluded in Boston with an exceptional display of biopharmaceutical innovation, regulatory dialogue, investment di...

June 20, 2025 | Friday | News
PharmaJet and Immuno Cure Partner to Advance Needle-Free HIV Therapeutic DNA Vaccine with Tropis® ID System

Agreement builds on PharmaJet’s strategy to be the best-in-class delivery system for novel DNA- and RNA-based vaccines and immunotherapies usin...

June 20, 2025 | Friday | News
BIO 2025 Day 2 Roundup: Innovation, Partnerships, and Global Momentum Define the Convention

Transformative Science and Global Health Solutions The convention floor buzzed with activity as Azitra, Inc. confirmed its pivotal presentation on novel...

June 18, 2025 | Wednesday | News
Ecolab Unveils Purolite AP+50 Resin to Enhance Cost-Efficiency and Performance in Antibody Manufacturing at BIO 2025

Ecolab Life Sciences announced it has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manuf...

June 17, 2025 | Tuesday | News
BioAro Launches PanOmiQ™ Research, Setting a New Standard for AI-Driven Multi-Omics and Drug Discovery

AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery.PanOmiQ™ Research sets a new global benchmark for prec...

June 17, 2025 | Tuesday | News
Integrated DNA Technologies Expands Infectious Disease Portfolio With Advanced Solutions for Global Research and Surveillance

Integrated DNA Technologies (IDT), a global genomics leader, is expanding its infectious disease portfolio with new solutions to enhance worldwide research...

June 17, 2025 | Tuesday | News
Enzene Adds 26,000 Sq. Ft. to NJ Facility, Unveils Expansion at BIO 2025

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, announced that ahead of the official opening of its biologics manufactu...

June 17, 2025 | Tuesday | News
BIO 2025 Opens in Boston, Uniting 20,000+ Global Biotech Leaders

The BIO International Convention, the world’s largest and most comprehensive event for the biotechnology industry, opens today in Boston. It wil...

June 17, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close